Page 27 - manuscript_ijb05590
P. 27

devices and competition with conventional microfabrication techniques further hinder

                   their translation from laboratory research to commercial and clinical adoption. Beyond

                   current applications, we explore how integration with novel biosensing modalities and
                   computational  analytics  could  revolutionize  personalized  cancer  diagnostics  and

                   treatment development.


                        3D-printed microfluidics demonstrate transformative potential in tumor research.

                   Building  upon  3D  printing,  4D  printing  introduces  a  temporal  dimension  through

                   stimulus-responsive systems activated by pressure, light, or heat, enabling dynamic

                   modulation of flow dynamics. The reversible shape-changing behavior of soft materials

                   enhances the flexibility and complexity of microfluidic actuator  149–151 . Utilizing shape-

                   memory polymers' (SMPs) phase-change capability to dynamically tune microchannel

                   geometries via thermal/optical stimuli  152 , next-generation tumor-on-chip models will

                   precisely  mimic  patient-specific  biology  and  enable  real-time  drug  delivery
                   optimization, advancing precision therapy.


                        However, 4D printing still faces considerable technical challenges, such as the

                   biocompatibility  and  long-term  stability  of  SMPs,  precise  control  over  stimulus

                   application, and reproducible dynamic responses under physiological conditions   153 .

                   Moreover, clinical  translation  is  hampered by significant  hurdles  including  chip-to-

                   human  physiological  discrepancies,  a  lack  of  standardization  in  fabrication  and

                   operational protocols, and the inherent complexity of integrating dynamic materials

                   into biomedical devices  154,155 .


                        Building  on  3D/4D  printing,  Lai  and  Wang   156   conceptualized  5D  printing:

                   embedded information (e.g., growth factors, nanoparticles, genetic/cellular data) as the

                   fifth dimension. 5D printing yields structures with shape-changing and information-
                   embedding capabilities that actively  interact  with  their  environment,  unlike passive

                   3D/4D  objects.  5D-printed  scaffolds  represent  a  transformative  advancement  in

                   biofabrication,  integrating  spatially  encoded  structural  information  with  dynamic,

                   stimuli-responsive  properties  that  actively  interface  with  native  biological

                   microenvironments.  These  sophisticated  constructs  achieve  two  paradigm-shifting
                                                            26
   22   23   24   25   26   27   28   29   30   31   32